FINWIRES · TerminalLIVE
FINWIRES

US Grants Accelerated Approval to BeOne Medicines' Blood Cancer Treatment Beqalzi

By

BeOne Medicines (SHA:688235, HKG:6160) said the U.S. Food and Drug Administration granted accelerated approval to Beqalzi to treat a type of rare blood cancer, according to a Thursday filing with the Hong Kong bourse.

The drug, also known as sonrotoclax, will be available for adult patients with relapsed or refractory mantle cell lymphoma who have failed at least two lines of system therapy.

Continued approval for this indication will remain contingent upon confirmation of clinical benefit in the ongoing trial of the medicine.

Beqalzi holds the breakthrough therapy, fast-track, and orphan drug designations in this indication, BeOne said.

Shares of the company were up over 2% in pre-market trade.

Related Articles

Asia

WiseTech Global Share Price Expected to Face Pressure After Largest Customer Signals Move Away from WiseTech Global's CargoWise, Jefferies Says

WiseTech Global's (ASX:WTC) share price is expected to come under pressure after DSV, one of its largest customers, decided to consolidate its air and sea transport management systems, transitioning away from CargoWise, Jefferies said in a Tuesday note.DSV confirmed its strategic shift from CargoWise to Schenker's Tango. However, this could be a multi-year journey, and DSV continues to migrate Schenker users into CargoWise.DSV spends about $150 million per year on CargoWise, representing around 9% of WiseTech's revenue and around 10% of earnings before interest, taxes, depreciation, and amortization (EBITDA) in fiscal 2027.The investment firm retained WiseTech Global's buy rating and AU$72 per share price target.

ASX:WTC
Asia

Ganfeng Lithium Cancels Stock Options on Missed Target; Shares Fall 4%

Ganfeng Lithium (SHE:002460, HKG:1772) canceled 551,250 stock options after failing to meet company performance goals for the fourth exercise period of its 2022 incentive plan.The cancellation was confirmed May 12 via the Shenzhen depository, according to a Wednesday filing with the Shenzhen bourse.The options were tied to fiscal years 2022 to 2025.Shares of the lithium miner fell 4% in recent trade on the Hong Kong bourse.

HKG:1772SHE:002460
Asia

South Korea to Raise Safety Inspections on Overseas Direct Purchases

South Korea plans to increase safety inspections on its overseas direct purchase on concerns about the influx of hazardous products amid an increase in cross-border e-commerce and online sales, the Office for Government Policy Coordination said in a Wednesday release.Safety inspections will be raised to over 2,000 by 2028 from about 1,000 cases in 2025.The government plans to boost inspection by applying data and AI across the entire product safety lifecycle and shifting toward preventive regulation, the release said.The initiative outlines four core strategies and 16 key tasks that are aimed at improving public confidence, it said.

^KOSDAQKOSPI